Monitor Corporation’s AI lung cancer diagnostic solution, MONCAD LCT (know as LuCAS plus in South Korea) , has been officially designated as a “New Health Technology with Deferred Evaluation” by the National Evidence-based Healthcare Collaborating Agency (NECA)—marking the first time a lung cancer solution using chest CT analysis has received this status in Korea. This designation allows MONCAD LCT to be used in Korean medical institutions as a non-reimbursed service supp

Monitor corp. had another successful booth at this year's KCR held at COEX in Seoul, South Korea. It was a great opportunity to meet with medical professionals from all over the world, introduce our major line up of MONCAD solutions (marketed under a different name in South Korea), and discuss the future of AI in medicine. We hope to meet more of you in the future

Monitor Corporation, a leading medical imaging AI solutions company (CEO Kyongjoon Lee has successfully raised 7 billion KRW in Series B funding. The round was led by UTC Investment, Premier Partners, and HB Investment.   Founded in 2018 by a team of radiology professors from Seoul National University Bundang Hospital, Monitor Corporation combines a deep understanding of medical practice wi th cutting-edge AI technology. Shortly after its launch, the company’s technical prowe

2023.10.10 Implementing AI-based computer-aided detection (CAD) software significantly enhances radiologists' accuracy in interpreting automated breast ultrasound (ABUS) exams, according to a study in Academic Radiology . Led by Mi-ri Kwon from Kangbuk Samsung Hospital, the research found that AI-CAD excels at detecting smaller cancers with lower BI-RADS categories and fewer retraction phenomena, thereby reducing oversight errors. In a study of 262 breast lesions, AI-CAD nota

2023.08.24 Monitor Corporation, a medical AI company led by CEO Lee Kyung-joon, announced on the 24th that its AI solution for early lung cancer diagnosis using CT scans has been designated as an "Outstanding R&D Innovation Product" by the Ministry of SMEs and Startups (MSS) for the first half of 2023. This AI solution is the first in its field to receive Class 3 medical device approval from the Ministry of Food and Drug Safety and to be recognized as an innovation product fo

2023.06.02 Hanshin Medipia will adopt Monitor Corporation's AI-based chest CT analysis solution for lung cancer diagnosis. The two companies signed an MOU to implement the AI solution, which is the first of its kind to receive Class 3 approval from the Ministry of Food and Drug Safety in Korea. Hanshin Medipia, despite having advanced imaging equipment, faced challenges in analyzing large volumes of CT data for lung cancer diagnosis. With this AI solution, they aim to offer m

2023.04.17 GE Healthcare, now an independent entity, is pushing forward with a vision to eliminate barriers in healthcare. In an interview, Jan Makela, President and CEO of GE Healthcare Imaging, shared insights on the company’s future, emphasizing their new mission: creating a world free of healthcare limitations. Makela introduced the "3D" approach, focusing on Devices, Digitalization, and Disease Pathways. GE Healthcare, already a leader in medical imaging technology, aims